Get the Stockscreener App
4.04
7.76%
-0.34
After Hours:
4.03
-0.010
-0.25%
Sonoma Pharmaceuticals Inc stock is traded at $4.04, with a volume of 55,034.
It is down -7.76% in the last 24 hours and down -13.68% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$4.38
Open:
$4.3
24h Volume:
55,034
Relative Volume:
0.05
Market Cap:
$6.64M
Revenue:
$12.31M
Net Income/Loss:
$-5.08M
P/E Ratio:
-4.2979
EPS:
-0.94
Net Cash Flow:
$-5.20M
1W Performance:
+1.25%
1M Performance:
-13.68%
6M Performance:
+94.23%
1Y Performance:
+34.67%
1-Day Range:
$4.01
$4.3034
1-Week Range:
$4.01
$4.60
52-Week Range:
$1.75
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
4.04 | 7.23M | 12.31M | -5.08M | -5.20M | -0.94 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Sonoma Pharmaceuticals Inc. recovery potential after sell off2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
Using RSI to spot recovery in Sonoma Pharmaceuticals Inc.2025 Key Lessons & Weekly Watchlist for Hot Stocks - newser.com
Is Sonoma Pharmaceuticals Inc. stock attractive for long term wealth buildingEarnings Summary Report & Intraday High Probability Setup Alerts - newser.com
Why Sonoma Pharmaceuticals Inc. (O8Z) stock is favored by hedge fundsJuly 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com
Will Sonoma Pharmaceuticals Inc. rebound enough to break even2025 Price Momentum & Community Driven Trade Alerts - newser.com
Analyzing Sonoma Pharmaceuticals Inc. with risk reward ratio chartsEarnings Beat & Technical Pattern Alert System - newser.com
Tools to assess Sonoma Pharmaceuticals Inc.’s risk profileJuly 2025 Action & Risk Managed Trade Strategies - newser.com
Real time scanner hits for Sonoma Pharmaceuticals Inc. explainedRate Hike & AI Powered Buy and Sell Recommendations - newser.com
How Sonoma Pharmaceuticals Inc. stock performs in interest rate cycles2025 Trading Recap & AI Enhanced Trading Signals - newser.com
Sonoma Pharmaceuticals’ (SNOA) Sell (D-) Rating Reiterated at Weiss Ratings - Defense World
How institutional ownership impacts Sonoma Pharmaceuticals Inc. stockGold Moves & Short-Term Trading Alerts - newser.com
Sonoma Pharmaceuticals (SNOA) Expands Reach with FDA Cosmetic Re - GuruFocus
Sonoma Pharmaceuticals registers under FDA’s cosmetics act - Investing.com
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA - ACCESS Newswire
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Sees Large Drop in Short Interest - Defense World
Can Sonoma Pharmaceuticals Inc. stock reach $100 price targetTrade Analysis Report & Verified Entry Point Signals - newser.com
Real time alert setup for Sonoma Pharmaceuticals Inc. performance2025 Short Interest & Real-Time Volume Triggers - newser.com
Is Sonoma Pharmaceuticals Inc. showing signs of accumulationBuy Signal & Breakout Confirmation Trade Signals - newser.com
Analyzing drawdowns of Sonoma Pharmaceuticals Inc. with statistical toolsWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Can Sonoma Pharmaceuticals Inc. (O8Z) stock sustain double digit ROEQuarterly Trade Review & Real-Time Volume Surge Alerts - newser.com
Is Sonoma Pharmaceuticals Inc. (O8Z) stock trading at attractive multiples2025 Volume Leaders & Long-Term Growth Stock Strategies - newser.com
Using fundamentals and technicals on Sonoma Pharmaceuticals Inc.July 2025 Outlook & Precise Trade Entry Recommendations - newser.com
Developing predictive dashboards with Sonoma Pharmaceuticals Inc. dataJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
Sonoma Pharmaceuticals Highlights Growth in Healthcare Sector - TipRanks
Published on: 2025-09-29 12:26:08 - newser.com
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):